Medication Template Insulin Lispro (Humalog) PDF

Preview

Summary

Download Medication Template Insulin Lispro (Humalog) PDF

Description

ACTIVE LEARNING TEMPLATE:

Medication

STUDENT NAME _____________________________________

Insulin Lispro (Humalog) MEDICATION __________________________________________________________________________ REVIEW MODULE CHAPTER ___________ Pharm ch.39

pancreatics(Pharm)/antidiabetics(Therapeutic) CATEGORY CLASS ______________________________________________________________________ PURPOSE OF MEDICATION

Expected Pharmacological Action ● Promotes cellular uptake of glucose (decreases glucose levels) ● Converts glucose into glycogen and promotes energy storage ● Moves potassium into cells (along with glucose)

Therapeutic Use Control of hyperglycemia in diabetic patients.

Complications ● Hypoglycemia ● Hypokalemia ● Lipohypertrophy

Contraindications/Precautions Contraindication: hypoglycemia; allergy or hypersensitivity to a particular type of insulin, preservatives, or other additives. Caution: stress and infection(may temporarily increased insulin requirements); renal/hepatic impariment(may decreased insulin requirements); Concomitant use with pioglitazone or rosiglitazone (increased risk of fluid retention and worsening HF; OB: pregnancy may temporarily increased insulin requirements.

Interactions ● Sulfonylureas, meglitinides, beta blockers, and alcohol have additive hypoglycemic effects with concurrent use. ● Concurrent use of thiazide diuretics and glucocorticoids can raise blood glucose levels and thereby counteract the effects of insulin. ● Beta blockers can mask SNS response to hypoglycemia(tachycardia, tremors), making it difficult for clients to identify hypoglycemia. Beta blockers also impair the body's natural ability to breakdown glycogen stores to raise blood glucose levels.

Evaluation of Medication Effectiveness Control of blood glucose levels in diabetic patients without the appearance of hypoglycemic or hyperglycemic episodes.

ACTIVE LEARNING TEMPLATES

Medication Administration Dose depends on blood glucose, response, and many other factors. Subcut ● Total insulin dose determined by needs of patient; generally 0.5~1 unit/kg/day;50~70% of dose may be given as meal-related boluses of rapid-acting insulin, and the remainde as an intermediate or long-acting insulin. ● Assess patient for signs and symptoms of hypoglycemia and hyperglycemia periodically during therapy ● Monitor body weight periodically. changes in weight may necessitate changes in insulin dose. ● LAB: blood glucose Q6hr, Hemoglobin A1c every 3~6 month to determine effctiveness, potassium ● Toxicity and overdose: overdose - hypoglycemia

Nursing Interventions • Because of the high error rate, 2 nurses must check the insulin type and dose. • Very rapid-acting agents are called “dose and eat” for a reason. Onset 5–15 min(very rapid acting) • Memorize the peak time of these medications; Look for hypoglycemia (normal 70–120 mg/dL). • Hypoglycemia looks like an anxiety attack with cold, clammy skin.

Client Education • Use U-100 syringes with solutions containing 100 units/mL. • Sick days require more monitoring. • Carry a source of glucose. • Wear a Medic-Alert bracelet. • Watch for signs and symptoms of hypoglycemia and hyperglycemia, and know what to do if they occur....